Valneva Reports Positive 12-Month Antibody Persistence Data

Valneva Reports Positive 12-Month Antibody Persistence Data for Single-Shot Chikungunya Vaccine Candidate

Valneva Reports Positive 12-Month Antibody Persistence Data for Single-Shot Chikungunya Vaccine Candidate
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

France , Brazil , Valneva Sevalneva , Juan Carlos Jaramillo , Joshua Drumm , Instituto Butantan , European Union Horizon , Fontainevp Global Communications European Investor Relations , Drug Administration , Wall Street , Biologics License Application , Euronext Paris , Chief Medical Officer , Breakthrough Therapy , Middle Income Countries , European Union , Adverse Event , Special Interest , Investors Contactsla , European Investor Relationsm , Investor Relationsm , Looking Statementsthis , Successfully Completes Pivotal Phase , Single Shot Chikungunya Vaccine Candidate , Reports Excellent Final Phase , Chikungunya Vaccine Candidate , Confirms Plans , Zine Analytics Chikungunya , Instituto Butantan Sign Final Agreement , Single Shot Chikungunya Vaccine ,